Lancet

the Lancet is a Russian loitering munition built by ZALA Aero , a subsidiary of the Kalashnikov Concern. It was unveiled at the Army-2019 defence expo and entered limited service the same year, fielded in two main variants: the smaller Lancet-1 with a roughly one-kilogram warhead, and the heavier Lancet-3 with a three-kilogram warhead and a quoted range of 40 to 70 kilometres. The system was designed by Alexander Zakharov’s team at ZALA and is intended as a precision strike weapon against artillery pieces, armoured vehicles, radars and parked aircraft — a niche that, before 2022, the Russian military had largely outsourced to fixed-wing strike aircraft and tube artillery.

The aircraft is a small, electrically-powered airframe with an X-shaped double tail and a distinctive cruciform wing configuration that gives it manoeuvrability in the terminal dive. Guidance is electro-optical: an operator selects a target through the seeker’s video feed in the final phase, and the munition steers itself onto the aimpoint. Later production lots, marketed as Lancet-3M and the Izdeliye-52 / 53 series, are claimed by ZALA to incorporate onboard target recognition that allows the weapon to lock onto a designated class of vehicle and complete the engagement without continuous operator input — a claim that is harder to verify from open footage, where most strikes still appear to involve a human in the loop. The Lancet typically works in a sensor-shooter pair with the Orlan-10 reconnaissance drone, which finds and fixes targets that the Lancet then prosecutes.

Russia is by some distance the dominant operator, and the war in Ukraine has been the system’s defining showcase. From late 2022 onwards, Lancets were used in growing numbers against Western-supplied artillery — M777 howitzers, Caesar self-propelled guns, PzH 2000s — as well as against S-300 and Buk air-defence systems and aircraft caught on dispersal airfields. Open-source trackers such as the Lostarmour database have catalogued thousands of claimed strike videos, making the Lancet one of the most heavily-documented loitering munitions in any conflict to date. Russian state media reported in 2023 that monthly production had been increased several times over to meet front-line demand, with assembly concentrated at the Kalashnikov-owned facility in Izhevsk.

Development has continued through the war. Reported upgrades include longer-range variants, a tube-launched version, and “carrier” drones that ferry multiple Lancets closer to the front before releasing them. Among contemporary loitering munitions, the Lancet sits between the smaller Switchblade-class weapons used by Ukrainian forces and heavier one-way attack systems such as the Iranian Shahed-136, occupying a tactical-strike role that has proven difficult for Ukraine to suppress despite extensive electronic-warfare and physical-screen countermeasures.